220 related articles for article (PubMed ID: 28775075)
1. First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis.
Adili R; Tourdot BE; Mast K; Yeung J; Freedman JC; Green A; Luci DK; Jadhav A; Simeonov A; Maloney DJ; Holman TR; Holinstat M
Arterioscler Thromb Vasc Biol; 2017 Oct; 37(10):1828-1839. PubMed ID: 28775075
[TBL] [Abstract][Full Text] [Related]
2. 12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in Platelets.
Yeung J; Tourdot BE; Adili R; Green AR; Freedman CJ; Fernandez-Perez P; Yu J; Holman TR; Holinstat M
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2068-77. PubMed ID: 27470510
[TBL] [Abstract][Full Text] [Related]
3. Docking and mutagenesis studies lead to improved inhibitor development of ML355 for human platelet 12-lipoxygenase.
Tsai WC; Aleem AM; Tena J; Rivera-Velazquez M; Brah HS; Tripathi S; D'silva M; Nadler JL; Kalyanaraman C; Jacobson MP; Holman T
Bioorg Med Chem; 2021 Sep; 46():116347. PubMed ID: 34507163
[TBL] [Abstract][Full Text] [Related]
4. Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy.
Tourdot BE; Holinstat M
Trends Pharmacol Sci; 2017 Nov; 38(11):1006-1015. PubMed ID: 28863985
[TBL] [Abstract][Full Text] [Related]
5. ML355 Modulates Platelet Activation and Prevents ABT-737 Induced Apoptosis in Platelets.
Shpakova V; Rukoyatkina N; Al Arawe N; Prilepskaya A; Kharazova A; Sharina I; Gambaryan S; Martin E
J Pharmacol Exp Ther; 2022 May; 381(2):164-175. PubMed ID: 35197320
[TBL] [Abstract][Full Text] [Related]
6. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
[TBL] [Abstract][Full Text] [Related]
7. Anti-thrombotic efficacy of S007-867: Pre-clinical evaluation in experimental models of thrombosis in vivo and in vitro.
Misra A; Prakash P; Aggarwal H; Dhankani P; Kumar S; Pandey CP; Pugh N; Bihan D; Barthwal MK; Farndale RW; Dikshit DK; Dikshit M
Biochem Pharmacol; 2018 Feb; 148():288-297. PubMed ID: 29309758
[TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase 1 is a novel pharmacological target for the development of an antiplatelet drug without bleeding side effects.
Vara D; Tarafdar A; Celikag M; Patinha D; Gulacsy CE; Hounslea E; Warren Z; Ferreira B; Koeners MP; Caggiano L; Pula G
FASEB J; 2020 Oct; 34(10):13959-13977. PubMed ID: 32851720
[TBL] [Abstract][Full Text] [Related]
9. Fatty acids negatively regulate platelet function through formation of noncanonical 15-lipoxygenase-derived eicosanoids.
Yamaguchi A; van Hoorebeke C; Tourdot BE; Perry SC; Lee G; Rhoads N; Rickenberg A; Green AR; Sorrentino J; Yeung J; Freedman JC; Holman TR; Holinstat M
Pharmacol Res Perspect; 2023 Feb; 11(1):e01056. PubMed ID: 36708179
[TBL] [Abstract][Full Text] [Related]
10. Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis.
Van Doren L; Nguyen N; Garzia C; Fletcher EK; Stevenson R; Jaramillo D; Kuliopulos A; Covic L
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e33-e45. PubMed ID: 33267659
[TBL] [Abstract][Full Text] [Related]
11. Plant-based Food Cyanidin-3-Glucoside Modulates Human Platelet Glycoprotein VI Signaling and Inhibits Platelet Activation and Thrombus Formation.
Yao Y; Chen Y; Adili R; McKeown T; Chen P; Zhu G; Li D; Ling W; Ni H; Yang Y
J Nutr; 2017 Oct; 147(10):1917-1925. PubMed ID: 28855423
[No Abstract] [Full Text] [Related]
12. [Antagonistic effect of 12-lipoxygenase inhibitor ML355 on lipopolysaccharide induced inflammatory response in mice].
Wang X; Tang W; Chen T; Luo L; Liang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Nov; 32(11):1378-1384. PubMed ID: 33463501
[TBL] [Abstract][Full Text] [Related]
13. Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice.
He H; Adili R; Liu L; Hong K; Holinstat M; Schwendeman A
Sci Adv; 2020 Dec; 6(49):. PubMed ID: 33277254
[TBL] [Abstract][Full Text] [Related]
14. Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis.
Petzold T; Thienel M; Konrad I; Schubert I; Regenauer R; Hoppe B; Lorenz M; Eckart A; Chandraratne S; Lennerz C; Kolb C; Braun D; Jamasbi J; Brandl R; Braun S; Siess W; Schulz C; Massberg S
Sci Transl Med; 2016 Nov; 8(367):367ra168. PubMed ID: 27903864
[TBL] [Abstract][Full Text] [Related]
15. Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters.
Deckmyn H; Stassen JM; Vreys I; Van Houtte E; Sawyer RT; Vermylen J
Blood; 1995 Feb; 85(3):712-9. PubMed ID: 7833475
[TBL] [Abstract][Full Text] [Related]
16. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
[TBL] [Abstract][Full Text] [Related]
17. Quercitrin inhibits platelet activation in arterial thrombosis.
Oh TW; Do HJ; Jeon JH; Kim K
Phytomedicine; 2021 Jan; 80():153363. PubMed ID: 33070081
[TBL] [Abstract][Full Text] [Related]
18. The chaperone protein HSP47: a platelet collagen binding protein that contributes to thrombosis and hemostasis.
Sasikumar P; AlOuda KS; Kaiser WJ; Holbrook LM; Kriek N; Unsworth AJ; Bye AP; Sage T; Ushioda R; Nagata K; Farndale RW; Gibbins JM
J Thromb Haemost; 2018 May; 16(5):946-959. PubMed ID: 29512284
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic and platelet function inhibiting effects of ML3000, a new antiinflammatory drug with Cox/5-LOX inhibitory activity.
Tries S; Laufer S; Radziwon P; Breddin HK
Inflamm Res; 2002 Mar; 51(3):129-34. PubMed ID: 12005203
[TBL] [Abstract][Full Text] [Related]
20. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
